Cargando…

The benefits of modified FOLFIRINOX for advanced pancreatic cancer and its induced adverse events: a systematic review and meta-analysis

FOLFIRINOX has been one of the first-line options for advanced pancreatic cancer, even though it induces significant adverse effects. Several institutions have begun using modified FOLFIRINOX to decrease its side effects and increase its tolerability. We systematically investigated the outcome from...

Descripción completa

Detalles Bibliográficos
Autores principales: Tong, Hongxuan, Fan, Zhu, Liu, Biyuan, Lu, Tao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5989209/
https://www.ncbi.nlm.nih.gov/pubmed/29875415
http://dx.doi.org/10.1038/s41598-018-26811-9